20 November 2017
News and Views
Links and Services
The latest issue of the Scandanavian Journal of Gastroenterology investigates cut-off levels and diagnostic accuracy of infliximab trough levels and anti-infliximab antibodies in Crohn's disease.
Reasons for infliximab failure in Crohn's disease and ulcerative colitis are debated.
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors